Valentina Greco | |
---|---|
Born | Palermo, Italy |
Alma mater | University of Palermo European Molecular Biology Laboratory/Max Planck Institute of Molecular Cell Biology and Genetics |
Spouse | Antonio J. Giraldez |
Children | 2 |
Scientific career | |
Doctoral advisor | Suzanne Eaton |
Other academic advisors | Elaine Fuchs |
Valentina Greco is an Italian-born biologist who teaches at the Yale School of Medicine as the Carolyn Walch Slayman Professor of Genetics and is an Associate Professor in the Cell Biology and Dermatology departments. Her research focuses on the role of skin stem cells in tissue regeneration.
Valentino Greco was born in Palermo, Italy, where she lived through her undergraduate program. After being denied admission to the graduate school at the University of Palermo, she was encouraged by her friend Eugenia Piddini to apply to the graduate program at the European Molecular Biology Laboratory. [1] Upon completion of her PhD, Greco moved to the United States and completed her postdoctoral work. She eventually decided to start her own lab, using a high-risk/high-reward approach alongside another Yale principal investigator, Ann Haberman. [2]
Greco is married to fellow Yale faculty member Antonio J. Giraldez, and they have two children, Lola and Gael. [1]
Greco received her undergraduate degree in Molecular Biology at the University of Palermo, Italy. In the final two years of her undergraduate program, Greco studied tumor suppressor genes in mitotic cell division in the lab of Aldo di Leonardo. [1] Greco then began graduate school in 1998 and received her PhD in 2002 from the European Molecular Biology Laboratory/Max Planck Institute of Molecular Cell Biology and Genetics (EMBL/MPI-CBG) in Heidelberg, Germany working with advisor Suzanne Eaton on tissue growth mechanisms. [3] She did her postdoctoral studies at Rockefeller University with Elaine Fuchs studying the mechanisms for stem cell activation during hair regeneration. [4]
The Greco lab currently studies stem cells in organ regeneration, with the goal of determining how cells are maintained despite mutation, cellular turnover, and injury. [5] Greco focuses on the mammalian hair follicle in mice to study cellular homeostasis, wound repair, and cancer. Her lab uses techniques such as in vivo imaging to track individual stem cells over time and understand how these cells act during homeostasis and respond to tissue injury. [5] Her lab has worked extensively on the importance of the spatial organization of stem cell niches [6] [7] and shown that these stem cells coordinate their differentiation and migration [8] and can clear away dead cells and tumor-like growths, [9] repairing significant faults in tissue structure. [10]
Greco's research has led to notable discoveries in cell regeneration, namely the mechanism of hair and skin regeneration. [11] Her findings show that hair germ cells are obtained from bulge stem cells, as well as suggest that hair germ cells initiate hair regeneration and stem cells drive the process. [4]
In more recent work, the Greco Lab uses stimulated emission depletion (STED) microscopy to gain three-dimensional images of cellular structures, and have been using this imaging to examine the brains of mice. [12] In her work with hair follicles and homeostasis, Greco has also determined a link between the lymphatic vessels of the skin and hair follicle development and organization. [13] The ongoing work of the Greco lab is looking to determine how skin reacts to mutations and the contribution of different tissue types to homeostasis. [5]
A scar is an area of fibrous tissue that replaces normal skin after an injury. Scars result from the biological process of wound repair in the skin, as well as in other organs, and tissues of the body. Thus, scarring is a natural part of the healing process. With the exception of very minor lesions, every wound results in some degree of scarring. An exception to this are animals with complete regeneration, which regrow tissue without scar formation.
Wound healing refers to a living organism's replacement of destroyed or damaged tissue by newly produced tissue.
In biology, regeneration is the process of renewal, restoration, and tissue growth that makes genomes, cells, organisms, and ecosystems resilient to natural fluctuations or events that cause disturbance or damage. Every species is capable of regeneration, from bacteria to humans. Regeneration can either be complete where the new tissue is the same as the lost tissue, or incomplete after which the necrotic tissue becomes fibrosis.
Regenerative medicine deals with the "process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. As of 2016, the only established therapy using stem cells is hematopoietic stem cell transplantation. This usually takes the form of a bone-marrow transplantation, but the cells can also be derived from umbilical cord blood. Research is underway to develop various sources for stem cells as well as to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes and heart disease.
Elaine V. Fuchs is an American cell biologist famous for her work on the biology and molecular mechanisms of mammalian skin and skin diseases, who helped lead the modernization of dermatology. Fuchs pioneered reverse genetics approaches, which assess protein function first and then assess its role in development and disease. In particular, Fuchs researches skin stem cells and their production of hair and skin. She is an investigator at the Howard Hughes Medical Institute and the Rebecca C. Lancefield Professor of Mammalian Cell Biology and Development at The Rockefeller University.
Sean J. Morrison is a Canadian-American stem cell biologist and cancer researcher. Morrison is the director of Children's Medical Center Research Institute at UT Southwestern, a nonprofit research institute established in 2011 as a joint venture between Children’s Health System of Texas and UT Southwestern Medical Center. The CRI was established in 2011 by Morrison with the mission to perform transformative biomedical research at the interface of stem cell biology, cancer, and metabolism to better understand the biological basis of disease. He is a Howard Hughes Medical Institute Investigator and member of the National Academy of Medicine. From 2015 to 2016 Morrison served as the president of the International Society for Stem Cell Research.
Fiona Watt, is a British scientist who is internationally known for her contributions to the field of stem cell biology. In the 1980s, when the field was in its infancy, she highlighted key characteristics of stem cells and their environment that laid the foundation for much present day research. She is currently director of the Centre for Stem Cells & Regenerative Medicine at King's College London, and Executive Chair of the Medical Research Council (MRC), the first woman to lead the MRC since its foundation in 1913. On 13 July 2021 she was appointed as the new Director of the European Molecular Biology Organization (EMBO).
Janet Rossant, is a developmental biologist well known for her contributions to the understanding of the role of genes in embryo development. She is a world renowned leader in developmental biology. Her current research interests focus on stem cells, molecular genetics, and developmental biology. Specifically, she uses cellular and genetic manipulation techniques to study how genes control both normal and abnormal development of early mouse embryos. Rossant has discovered information on embryo development, how multiple types of stem cells are established, and the mechanisms by which genes control development. In 1998, her work helped lead to the discovery of the trophoblast stem cell, which has assisted in showing how congenital anomalies in the heart, blood vessels, and placenta can occur.
The stem cell theory of aging postulates that the aging process is the result of the inability of various types of stem cells to continue to replenish the tissues of an organism with functional differentiated cells capable of maintaining that tissue's original function. Damage and error accumulation in genetic material is always a problem for systems regardless of the age. The number of stem cells in young people is very much higher than older people and thus creates a better and more efficient replacement mechanism in the young contrary to the old. In other words, aging is not a matter of the increase in damage, but a matter of failure to replace it due to a decreased number of stem cells. Stem cells decrease in number and tend to lose the ability to differentiate into progenies or lymphoid lineages and myeloid lineages.
Helen Margaret Blau is an American biologist and the Donald E. and Delia B. Baxter Foundation Professor and Director of the Baxter Laboratory for Stem Cell Biology at Stanford University School of Medicine. She is known for establishing the reversibility of the mammalian differentiated state. Her landmark papers showed that nuclear reprogramming and the activation of novel programs of gene expression were possible, overturning the prevailing view that the differentiated state was fixed and irreversible. Her discoveries opened the door for cellular reprogramming and its application to stem cell biology.
Amy J. Wagers is the Forst Family Professor of Stem Cell and Regenerative Biology at Harvard University and Harvard Medical School, an investigator in islet cell and regenerative biology at the Joslin Diabetes Center, and principal faculty of the Harvard Stem Cell Institute. She is co-chair of the Department of Stem Cells and Regenerative Biology at Harvard Medical School.
Regeneration in humans is the regrowth of lost tissues or organs in response to injury. This is in contrast to wound healing, or partial regeneration, which involves closing up the injury site with some gradation of scar tissue. Some tissues such as skin, the vas deferens, and large organs including the liver can regrow quite readily, while others have been thought to have little or no capacity for regeneration following an injury.
Valerie Horsley is an American cell and developmental biologist. She currently works as an associate professor at Yale University, where she has extensively researched the growth, restoration, and maintenance of skin cells. She is a currently a member of the Yale Cancer Center and Yale Stem Cell Center. She received a Presidential Early Career Award for Scientists and Engineers in 2012 and in 2013 she was the recipient of the Rosalind Franklin Young Investigator Award.
The stem cell secretome is a collective term for the paracrine soluble factors produced by stem cells and utilized for their inter-cell communication. In addition to inter-cell communication, the paracrine factors are also responsible for tissue development, homeostasis and (re-)generation. The stem cell secretome consists of extracellular vesicles, specifically exosomes, microvesicles, membrane particles, peptides and small proteins (cytokines). The paracrine activity of stem cells, i.e. the stem cell secretome, has been found to be the predominant mechanism by which stem cell-based therapies mediate their effects in degenerative, auto-immune and/or inflammatory diseases. Though not only stem cells possess a secretome which influences their cellular environment, their secretome currently appears to be the most relevant for therapeutic use.
Cédric Blanpain is a Belgian researcher in the field of stem cells. He is a tenured professor of developmental biology and genetics at Université Libre de Bruxelles and director of the stem cell and cancer lab at its Faculty of Medicine. He was one of the first researchers in the world to use cell lineage tracing in cancer research and he showed for the first time the existence of cancer stem cells in solid tumors in vivo. He was selected by Nature as one of 10 People who mattered most in 2012 and he received the outstanding young investigator award of the International Society for Stem Cell Research.
Cheng-Ming Chuong is a Taiwanese-American biomedical scientist.
Dermal macrophages are macrophages in the skin that facilitate skin homeostasis by mediating wound repair, hair growth, and salt balance. Their functional role in these processes is the mediator of inflammation. They can acquire an M1 or M2 phenotype to promote or suppress an inflammatory response, thereby influencing other cells' activity via the production of pro-inflammatory or anti-inflammatory cytokines. Dermal macrophages' ability to acquire pro-inflammatory properties also potentiates them in cancer defence. M1 macrophages can suppress tumour growth in the skin by their pro-inflammatory properties. However, M2 macrophages support tumour growth and invasion by the production of Th2 cytokines such as TGFβ and IL-10. Thus, the exact contribution of each phenotype to cancer defence and the skin's homeostasis is still unclear.
Anjali Kusumbe is a British-Indian biologist who is the Head of the Tissue and Tumour Microenvironments Group at the Medical Research Council Human Immunology Unit and Weatherall Institute of Molecular Medicine at the University of Oxford. She was awarded the Royal Microscopical Society Award for Life Sciences in 2022.
Emi K. Nishimura is a Japanese biologist who is Professor of Ageing and Regeneration at the University of Tokyo. Her research considers the molecular mechanisms that underpin ageing. She was elected Fellow of the National Academy of Sciences in 2022.